Buscar
Mostrando ítems 1-10 de 865
Úlcera cecal única como presentación de enfermedad de Crohn
(Sociedad de Gastroenterología del Perú (SGP), 2014-08-04)
Crohn s Disease, is a rare inflammatory bowel disease in Perú. Incidence rates vary from 1,6 – 14,6 / 100 000 and prevalence rate is 140 / 100000 in the western hemisphere. We report a case of 52 y.o male patient from ...
Infliximab-induced psoriasis during therapy for Crohn's disease
(Elsevier B.V., 2012-06-01)
Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, ...
Infliximab-induced psoriasis during therapy for Crohn's disease
(Elsevier B.V., 2012-06-01)
Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, ...
Oxidative stress, prooxidants and Crohn disease Estrés oxidativo, prooxidantes y enfermedad de Crohn
(2006)
The frequency of Crohn disease shows a significant increase in the last century. Affected patients show a misbalance between production of free radicals and anti oxidant defenses. Thus, one of the increasingly accepted ...
Composição corporal de pacientes com doença de Crohn e colite ulcerativa
(2017-01-01)
Background – The nutritional status of individuals with inflammatory bowel diseases is directly related to the severity of the disease and is associated with poor prognosis and the deterioration of immune competence. ...
Hidradenitis suppurativa as a paradoxical side effect to the use of adalimumab in patients with crohn’s disease?
(2020-01-01)
Background: Hidradenitis suppurativa is a chronic inflammatory skin disorder associated with inflammatory bowel disease. However, it can arise as a paradoxical side effect of antiTNF treatment. Methods: The article reports ...
ABDOMEN AGUDO OBSTRUCTIVO POR ENFERMEDAD DE CROHN: CASO CLINICO
(Instituto Médico "Sucre", 2023)